期刊文献+

唑来膦酸治疗恶性肿瘤骨转移的不良反应护理体会 被引量:1

Nursing Experience of Adverse Effects of the Treatment of Bone Metastases From Malignant Tumor
下载PDF
导出
摘要 目的分析使用唑来膦酸治疗恶性肿瘤骨转移不良反应的护理体会。方法选择2013年10月~2015年6月我院收治的恶性肿瘤骨转移患者共100例,分为对照组(常规护理组)和观察组(护理干预组)各50例,比较不良反应与满意度。结果观察组不良反应较对照组少,满意度较对照组高,差异有统计学意义。结论对于唑来膦酸治疗恶性肿瘤骨转移的不良反应,采取针对性干预性护理可有利于患者康复。 Objective To analysis using azole phosphonic acid treatment for malignant tumors of bone metastasis experience from the nursing of adverse reactions. Methods 100 patients with malignant bone metastases in our hospital from October 2013 to June 2015, were divided into control group(conventional care group) and observation group(nursing intervention group) 50 cases, the adverse reaction and satisfaction. Results Observation group adverse reaction less than the control group, high satisfaction than the control group, the difference was statistically significant. Conclusion Thiazole to phosphonic acid in the treatment of malignant tumor of bone metastases adverse reaction, adopting the interventional nursing rehabilitation can be beneficial to patients.
作者 于美瑛
出处 《中国继续医学教育》 2016年第7期257-259,共3页 China Continuing Medical Education
关键词 唑来膦酸 恶性肿瘤 骨转移 不良反应 护理体会 Zoledronic acid Malignant tumor Osseous metastasis Adverse reaction Nursing Care
  • 相关文献

参考文献8

二级参考文献33

  • 1申戈,宋三泰,江泽飞,卞寿庚,谢广茹,王雅杰,王杰军.唑来磷酸治疗恶性肿瘤引起高钙血症的临床研究[J].中华肿瘤杂志,2005,27(10):632-634. 被引量:18
  • 2马成青,张婕,尚玉芬.唑来膦酸治疗恶性肿瘤骨转移瘤疼痛的临床观察与护理[J].实用医技杂志,2006,13(23):4169-4170. 被引量:4
  • 3Bradley S, Sherwood PR, Donovan HS, et al. I could lose everything: understanding the cost of a brain tumor[ J]. J Neurooncol, 2007, 85(3) : 329 -338.
  • 4Reich CD. Advances in the treatment of bone metastases[ J]. Clin J Oncol Nurs, 2003, 7(6) : 641 -646.
  • 5Bǎekman U, Svensson A, Christofferson RH, et al. The bisphosphonate, zoledronie acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis[ J]. Anticaneer Res, 2008, 28(3A) : 1551 - 1557.
  • 6Machado M, Cruz LS, Tannus G, et al. Efficacy of clodronate, pamidronate, and in reducing morbidity and mortality in cancer patients with bone metastasis: zoledronate a meta - analysis of randomized clinical trials [ J ]. Clin Ther, 2009, 31 (5) : 962 - 979.
  • 7Body JJ. Dosing regimens and main adverse events of bisphosphonates[J]. Sere Oncol, 2001,28( 11 ) : 49 -53.
  • 8Cameron D, Fallon M, Die1 I. Ibandronate: Its role in metastatic breast cancer[ J]. Oncologist,2006,22 ( suppl - 1 ) : 27 - 33.
  • 9Zahrowski JJ. Osteonecrosis of the jaw is associated with highdose bisphosphonate treatment in patients with cancer[ J]. J Am Dent Assoc, 2010, 141(7) : 887 -888.
  • 10Abe M. New development in bisphosphonate treatment. Treatment with bisphosphonates for cancer - induced bone disease [ J ]. Clin Calcium, 2009, 9(1): 55-62.

共引文献26

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部